Sep 12, 2023 / 09:00PM GMT
Yih-Ming Tu - Morgan Stanley, Research Division - Research Associate
Good afternoon, everyone, and welcome to Day 2 of the Morgan Stanley Global Healthcare Conference. My name is Edmund Tu, and I work on the Life Science Tools team. Before we begin, I'd like to remind everyone that important research disclosures can be found at morganstanley.com/researchdisclosures. And with that, I'm very excited to have Mr. Brad Gray; and Mr. Tom Bailey, CEO and CFO of NanoString on stage with me today.
Brad, I think you wanted to start with a presentation.
R. Bradley Gray - NanoString Technologies, Inc. - CEO, President & Director
That's right. And I appreciate you accommodating us. Given the recent volatility in our share price, the management team and I decided to release this morning a slide set and file an 8-K, providing some updated information that we think will help investors understand the intrinsic value of our company. We've been having constructive investor discussions all day on these materials. And if you're following on the webcast,
NanoString Technologies Inc at Morgan Stanley Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot